First evidence of a HIV-1 M/O recombinant form circulating outside Cameroon

AIDS

Volumn 24, Issue 7, 2010, Pages 1079-1082

  Vessière, Aurélia ^a,b   Leoz, Marie ^a   Brodard, Véronique ^c   Strady, Christophe ^d   Lemée, Véronique ^a   Depatureaux, Agnès ^a   Simon, François ^d   Plantier, Jean Christophe ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^c REIMS UNIVERSITY HOSPITAL   (France)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAMEROON; GENETIC VARIABILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS STRAIN; VIRUS TRANSMISSION;

ADULT; CAMEROON; CD4 LYMPHOCYTE COUNT; FEMALE; FRANCE; GENETIC VARIATION; HIV INFECTIONS; HIV-1; HUMANS; RECOMBINATION, GENETIC; RNA, VIRAL;

EID: 77950930686     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283355659     Document Type: Letter

References (13)

1. Plantier JC, Leoz M, Dickerson JE, De Oliveira F, Cordonnier F, Lemée V, et al. A new human immunodeficiency virus derived from gorillas. Nat Med 2009; 15:871-872.
2. VergneL, Bourgeois A,Mpoudi-Ngole E, Mougnutou R,Mbuag-baw J, Liegeois F, et al. Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02-AG variant and disease stage. Virology 2003; 310:254-266.
3. Yamaguchi J, Bodelle P, Vallari AS, Coffey R, McArthur CP, Schochetman G, et al. HIV infections in northwestern Cameroon: identification of HIV type 1 group O and dual HIV type 1 group M and group O infections. AIDS Res Hum Retroviruses 2004; 20:944-957.
4. Vessiere A, Rousset D, Kfutwah A, Leoz M, Depatureaux A, Simon F, Plantier JC. Diagnosis and monitoring of HIV-O infected patients in Cameroon. J Acquir Immune Defic Syndr 2010 (in press).
5. Peeters M, Liegeois F, Torimiro N, Bourgeois A, Mpoudi E, Vergne L, et al. Characterization of a highly replicative inter-group M/O human immunodeficiency virus type 1 recombi-nant isolated from a Cameroonian patient. J Virol 1999; 73:7368-7375.
6. Takehisa J, Zekeng L, Ido E, Yamaguchi-Kabata Y, Mboudjeka I, Harada Y, et al. Human immunodeficiency virus type 1 inter-group (M/O) recombination in Cameroon. J Virol 1999; 73:6810-6820.
7. Simon F, Souquière S, Damond F, Kfutwah A, Makuwa M, Leroy E, et al. Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses. AIDS Res Hum Retroviruses 2001; 17:937-952.
8. Barin F, Plantier JC, Brand D, Brunet S, Moreau A, Liandier B, et al. Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic. J Med Virol 2006; 78 (Suppl 1):S13-S18.
9. Gueudin M, Lemee V, Ferre V, Beby-Defaux A, Pathé JP, Guist'hau O, et al. Virologic diagnosis and follow-up of children born to mothers infected by HIV-1 group O. J Acquir Immune Defic Syndr 2004; 36:639-641.
10. Rouet F, Chaix ML, Nerrienet E, Ngo-Giang-Huong N, Plantier JC, Burgard M, et al. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymer-ase chain reaction test. J Acquir Immune Defic Syndr 2007; 45:380-388.
11. Plantier JC, Dachraoui R, Lemée V, Gueudin M, Borsa-Lebas F, Caron F, Simon F. HIV-1 resistance genotyping on dried serum spots. AIDS 2005; 19:391-397.
12. Leoz M, Depatureaux A, Vessière A, Roquebert B, Damond F, Rousset D, et al. Integrase polymorphism and HIV-1 group O diversity. AIDS 2008; 22:1239-1243.
13. Archer J, Pinney JW, Fan J, Simon-Loriere E, Arts EJ, Negroni M, et al. Identifying the important HIV-1 recombination breakpoints. PLoS Comput Biol 2008; 4:e1000178